Mr. Speaker, I would like to thank my colleague for his intervention. It was very interesting. He spoke today a bit about the AstraZeneca vaccine and the public dollars that went into developing it. I have to say, I am excited because today I was able to get the AstraZeneca vaccine in my arm. That is great news for me.
When we talk about the public dollars going into AstraZeneca, one of the big concerns I have, and I have raised it in the House many times, is the Canadian government's unwillingness to allow for intellectual property rights to be waived so that other countries can access the vaccine so they can continue to make sure that people around the world are getting the vaccine. Public dollars went into the development of these vaccines, so I do not understand why there is not that impetus for public good through the IP waiver system, the TRIPS waivers.
Would he be willing to support that if we could get the Bloc to support waiving that intellectual property right?